SLC8A2 is encoded on chromosome 19q13.3, and loss of heterozygosity at 19q13.3 is both a common genetic change in human gliomas [25] and a prognostic marker for predicting overall survival [26]. Here, SLC8A2 is linked to central nervous system cancer.